Skip to main content

Blog

The Duchenne Registry Has a New Gene Therapy Survey!

...

Join Us in Orlando for PPMD’s 30th Annual Conference

...

Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne

...

REGENXBIO Shares New Positive Initial Efficacy Data From AFFINITY DUCHENNE Trial

...

PPMD Hosts Town Hall on Clinical Trials During 2024 Advocacy Conference

...

PPMD Celebrates 30th Anniversary and Three Decades of Progress with Annual Advocacy Conference

...

Breaking News: Rare Disease Day Congressional Hearing to Address the BENEFIT Act

...

Watch: Overview of WVE-N531 and the FORWARD-53 Clinical Trial with Wave Life Sciences (Webinar Recording)

...

Revised Community-Led Duchenne Guidance Published: Developing Potential Treatments for the Entire Spectrum of Disease

...

PPMD Announces Pediatric Certified Duchenne Care Center at Penn State Health Children’s Hospital

...